Studies report increased m6A methylation in ALS spinal cord tissue, with mutations in Fused in sarcoma (FUS) and TDP-43 linked to altered m6A signaling pathways contributing to disease pathology [75,76,77]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.